Back to the main directory
Press Release
- EQS-News: Novem Group S.A.: Novem Group S.A.: Hauptversammlung beschließt Dividende von €1,15 je Aktie by EQS Group AG
- Hepsiburada Announces Second Quarter 2023 Financial Results by GlobeNewsWire
- FactSet Schedules Fourth Quarter 2023 Earnings Call by GlobeNewsWire
- A New Chilled Ritual is Here: Solei Cannabis Launches Its First Sparkling CBD Beverages by GlobeNewsWire
- Destination XL Group, Inc. Reports Second Quarter Financial Results by GlobeNewsWire
- Hain Celestial Reports Fourth Quarter and Fiscal Year 2023 Financial Results by GlobeNewsWire
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- Meldepliktig handel primærinnsider by GlobeNewsWire
- Rekordregnskab hos Fynske Bank by GlobeNewsWire
- Aprea Therapeutics Appoints Dr. Jean-Pierre Bizzari to its Board of Directors and Names Dr. Richard Peters as Chairman by GlobeNewsWire
- EDDYLINE BREWING IS THE FIRST NEW ZEALAND BREWERY TO INSTALL CHART INDUSTRIES’ EARTHLY LABS CO2 CAPTURE TECHNOLOGY by GlobeNewsWire
- Deep-South Announces Private Placement for Gross Proceeds of Up to C$2,000,000 by GlobeNewsWire
- Incannex to Prepare FDA IND Application for Psilocybin-assisted Psychedelic Psychotherapy Program, Known as Psi-GAD by GlobeNewsWire
- PyroGenesis Confirms Receipt of $445,200 Milestone Payment for SPARC™ Land-Based Waste Destruction System by GlobeNewsWire
- EQS-News: Deutsche Börse AG: Deutsche Börse erhält letzte regulatorische Genehmigung für öffentliche Übernahme von SimCorp by EQS Group AG
- Navios Maritime Holdings Inc. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2023 by GlobeNewsWire
- CeMat foretager udviklingsinvestering i boligejendom med detailhandel i stueplan by GlobeNewsWire
- Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon by BusinessWire
- AEON Biopharma Receives Notice of Allowance from USPTO for a Patent Covering Use of Botulinum Toxins to Treat Migraine Headache by GlobeNewsWire
- Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections by GlobeNewsWire
- GK Financing LLC, a Subsidiary of American Shared Hospital Services, Announces Extension of Agreement with Methodist Hospital Merrillville, Indiana by GlobeNewsWire
- Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing Requirements by GlobeNewsWire
- STRATA Skin Sciences to Host Virtual KOL Event on XTRAC® and TheraClear®X by GlobeNewsWire
- Taysha Gene Therapies Announces Fast Track Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome by GlobeNewsWire
- Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026 by GlobeNewsWire